Copyright © 1993 by the European Society of Cardiology.
© 1993 The Europen Society of Cardiology
Prevalence of coronary heart disease in Icelandic Men 19681986
The Reykjavik Study
Heart Preventive Clinic and Department of Medicine, Landspitalinn, National University Hospital of Iceland Reykjavik, Iceland
Received 6 July 1992; revised 18 November 1992; .
Correspondence: Nikulás Sigfússon, Heart Preventive Clinic. Lágmúla 9, 108 Reykjavik, Iceland
Abstract
The prevalence of coronary heart disease (CHD) was determined in a general population sample of 9141 Icelandic men aged 3479 years, and the prevalence of four different forms of CHD was estimated separately: symptomatic infarction fulfilling WHOMONICA criteria for definite myocardial infarction; myocardial infarction detected by ECG changes only (unrecognized, silent infarction); angina pectoris detected by the Rose questionnaire and associated with ECG manifestations of myocardial ischaemia, either at rest or during exercise, but no manifestations of myocardial infarction; angina pectoris without ECG changes indicative of myocardial ischaemia. The study was conducted in five stages allowing evaluation of trends from 19681986
Age was a major determinant of the prevalence of all forms of CHD. Thus, the prevalence of myocardial infarction (symptomatic or silent) rose from undetectable levels in the youngest age group (3034 years) to around 12% (7% symptomatic and 5% silent) in the oldest group (7579 years) and the prevalence of all forms of CHD rose from 4% in the youngest age group to 23% in the age group 7074 years. Age-standardized comparison was carried out on the prevalence of the different forms of CHD at different stages of the study in 5064-year-old men who were represented in all stages of the study. There was a gradual increase in the prevalence of myocardial infarction from 3% (symptomatic and silent combined, CI 1.948) in 1968 to 4.9% in 1986 (CI 3.96.1) (P<0.001). Conversely there was a statistically significant fall in the prevalence of angina pectoris, with or without ECG-manifestations of myocardial ischaemia, from 11.3% (CI 8.814.4) in 1968 to 5% in 1986 (CI 4.06.2) (P<0.001). This decrease was of sufficient magnitude to more than offset the rise in infarct prevalence, resulting in a significant fall in the prevalence of all CHD from 14.3% (CI 11.517.8) in 1968 to9.9% (CI 8.511.5) in 1986 in 5064-year-old men. This trend is in general agreement with the previously reported decline in age-standardized mortality from CHD and the incidence of myocardial infarction in Iceland.
Key Words: Coronary heart disease epidemiological survey prevalence
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Torabi, J. G.F. Cleland, N. K. Khan, P. H. Loh, A. L. Clark, F. Alamgir, J. L. Caplin, A. S. Rigby, and K. Goode The timing of development and subsequent clinical course of heart failure after a myocardial infarction Eur. Heart J., April 1, 2008; 29(7): 859 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Daly, F. Clemens, J. L. Lopez-Sendon, L. Tavazzi, E. Boersma, N. Danchin, F. Delahaye, A. Gitt, D. Julian, D. Mulcahy, et al. The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina Eur. Heart J., June 1, 2006; 27(11): 1298 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O. Arnar, S. Thorvaldsson, T. A. Manolio, G. Thorgeirsson, K. Kristjansson, H. Hakonarson, and K. Stefansson Familial aggregation of atrial fibrillation in Iceland Eur. Heart J., March 2, 2006; 27(6): 708 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kattainen, V. Salomaa, T. Harkanen, A. Jula, R. Kaaja, Y. A. Kesaniemi, M. Kahonen, L. Moilanen, M. S. Nieminen, A. Aromaa, et al. Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s Eur. Heart J., February 1, 2006; 27(3): 296 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Daly, F. Clemens, J. L. Lopez Sendon, L. Tavazzi, E. Boersma, N. Danchin, F. Delahaye, A. Gitt, D. Julian, D. Mulcahy, et al. Gender Differences in the Management and Clinical Outcome of Stable Angina Circulation, January 31, 2006; 113(4): 490 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Thorgeirsson, G. Thorgeirsson, H. Sigvaldason, and J. Witteman Risk factors for out-of-hospital cardiac arrest: the Reykjavik Study Eur. Heart J., August 1, 2005; 26(15): 1499 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Daly, F. Clemens, J. L. L. Sendon, L. Tavazzi, E. Boersma, N. Danchin, F. Delahaye, A. Gitt, D. Julian, D. Mulcahy, et al. The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina Eur. Heart J., May 2, 2005; 26(10): 996 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gunnarsdottir, B. E Birgisdottir, I. Thorsdottir, V. Gudnason, and R. Benediktsson Size at birth and coronary artery disease in a population with high birth weight Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1290 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kattainen, A. Reunanen, S. Koskinen, T. Martelin, P. Knekt, and A. Aromaa Secular changes in prevalence of cardiovascular diseases in elderly Finns Scand J Public Health, October 1, 2002; 30(4): 274 - 280. [Abstract] [PDF] |
||||
![]() |
B. E Birgisdottir, I. Gunnarsdottir, I. Thorsdottir, V. Gudnason, and R. Benediktsson Size at birth and glucose intolerance in a relatively genetically homogeneous, high-birth weight population Am. J. Clinical Nutrition, August 1, 2002; 76(2): 399 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
F C Lampe, R W Morris, P H Whincup, M Walker, S Ebrahim, and A G Shaper Is the prevalence of coronary heart disease falling in British men? Heart, November 1, 2001; 86(5): 499 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Agnarsson, G. Thorgeirsson, H. Sigvaldason, and N. Sigfusson Effects of Leisure-Time Physical Activity and Ventilatory Function on Risk for Stroke in Men: The Reykjavik Study Ann Intern Med, June 15, 1999; 130(12): 987 - 990. [Abstract] [Full Text] [PDF] |
||||





